Success Stories: NIW Petition Approved in Under a Month for Visiting Postdoctoral Fellow’s Vital Work in Drug Resistance Mechanisms
Client’s Testimonial:
“I worked with Chen Immigration & Attorneys for my NIW-EB2 petition, and it was approved without any RFEs. Their team consistently responded to my questions promptly and provided detailed, informative answers. All documents were professionally drafted, and they made the entire process smooth and stress-free. I would gladly recommend Chen Immigration & Attorneys to anyone interested in applying for a green card.”
On June 2nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Visiting Postdoctoral Fellow in the Field of Cancer Biology (Approval Notice).
General Field: Cancer Biology
Position at the Time of Case Filing: Visiting Postdoctoral Fellow
Country of Origin: Taiwan
State of Residence at the Time of Filing: Maryland
Approval Notice Date: June 2nd, 2025
Processing Time: 26 days (Premium Processing Requested)
Case Summary:
For our client, cancer research is more than a scientific pursuit, it’s a mission to improve patient survival through smarter therapies. His work explores the intricate molecular mechanisms behind tumor progression and drug resistance, laying the foundation for advanced combination therapies that offer safer and more effective treatment options.
With cancers evolving resistance to conventional treatments, his research identifies novel therapeutic targets that inform new treatment paradigms. His approach, deeply rooted in precision medicine, bridges laboratory innovation with real-world clinical relevance, addressing one of the most urgent challenges in modern oncology.
To continue this impactful work from within the U.S., the client partnered with the North America Immigration Law Group (NAILG) to file a National Interest Waiver (NIW) petition. Despite the absence of recommendation letters, NAILG’s legal team successfully articulated the national significance of our client’s contributions, building a case centered on tangible outcomes and peer recognition.
His accomplishments include:
➔ 10 peer-reviewed journal articles, including 2 first-authored,
➔ 4 conference abstracts, 1 first-authored,
➔ A citation count of 379, reflecting widespread academic influence, and
➔ Unsolicited speaking invitations from prominent scientific conferences are a testament to his standing in the field.
Together, this body of work presented a compelling narrative: our client is not only conducting high-level cancer research but is also driving innovation that directly benefits public health. With NAILG’s strategic guidance, USCIS approved the NIW petition, clearing the path for him to continue advancing cancer treatment strategies in the United States.This approval is more than a legal milestone; it’s a validation of our client’s role in shaping the future of cancer therapy and a testament to the power of science backed by thoughtful legal advocacy.

